Lung cancer diagnosis in England often stretches across weeks of imaging and emergency care
A national real-world analysis from England shows how often lung cancer diagnosis unfolds slowly, with repeated imaging and substantial emergency department use along the way. Among 21,052 adults newly diagnosed between April 2018 and March 2019, the median diagnostic interval from first chest imaging to diagnosis was 56 days. One in four patients waited at least 113 days. Those numbers matter because lung cancer is a time-sensitive disease in which delay can allow local invasion, metastatic spread and clinical deterioration long before definitive treatment begins.
The study examined linked Hospital Episode Statistics and Diagnostic Imaging Dataset records, giving a population-level view of how patients moved through the diagnostic pathway rather than how an idealized referral system is supposed to work. The picture that emerges is not of a single bottleneck but of a process that often appears fragmented, with multiple imaging episodes, repeated re-evaluation and frequent acute-care contact. In a disease where symptoms can be vague and radiology often becomes the first objective clue, every extra step in the pathway can push diagnosis further from the initial clinical suspicion.
Repeated chest imaging tracked with longer diagnostic timelines
Patients underwent a median of three chest scans before diagnosis, and 25% received four or more. Multimodality imaging was strongly associated with prolonged diagnostic intervals. In practical terms, this suggests that many patients did not move through a clean linear route from suspicion to confirmation. Instead, the workup frequently required several imaging modalities, likely because the initial scan did not fully resolve the diagnostic question or because disease complexity demanded further clarification.
A longer imaging sequence can reflect genuine clinical difficulty: lesions may be subtle, anatomy may be distorted by chronic lung disease, and suspicious findings may sit in a gray zone between benign and malignant. But repeated imaging can also signal delay in coordination, delayed escalation, or duplicated investigations across settings. For a patient with evolving symptoms, each additional scan can become another interval in which cancer remains untreated and uncertainty persists.
The association between multimodality imaging and a longer diagnostic interval should not be read as proof that imaging itself is harmful. Chest imaging is indispensable in lung cancer diagnosis. The issue is the pace and coherence of the pathway after the first abnormal study appears.
A&E attendance was common during the diagnostic pathway
One-third of patients attended A&E during the diagnostic pathway, rising to 45% among those with the longest intervals. That pattern is clinically important. Emergency attendance during cancer workup often reflects symptom escalation, acute breathlessness, pain, hemoptysis, infection, or a system failure in which a deteriorating patient reaches hospital before the outpatient pathway closes the diagnostic loop.
Emergency care use also changes the meaning of the diagnostic interval itself. A pathway that includes repeated A&E contact is not simply “slow”; it may be unstable, reactive and poorly coordinated. In lung cancer, this can mean that diagnosis is being assembled under pressure rather than through planned outpatient assessment. A patient who keeps reappearing in acute care may experience a very different sequence than someone moving smoothly through primary care referral and rapid imaging review.
The study’s findings suggest that emergency care is not a rare exception in lung cancer diagnosis in England. It is part of the pathway for a large share of patients, especially those with the longest delays.
Longer waits affected all deprivation groups, while Asian patients had the longest median interval
Diagnostic intervals and high A&E attendance were seen across deprivation quintiles, pointing to a system-wide problem rather than one confined to a single socioeconomic stratum. The pattern is notable because it suggests that delayed diagnosis is not only a function of poverty or deprivation, even though those factors often shape access, presentation and outcomes in cancer care. The diagnostic pathway appears stretched across the board.
Asian patients experienced the longest diagnostic intervals, with a median of 67 days. The study does not by itself explain why this difference exists, but the signal is clinically relevant and should not be ignored. Potential contributors could include differences in symptom presentation, communication barriers, help-seeking behavior, referral patterns, or the way imaging and follow-up are coordinated after the first presentation. None of those explanations can be confirmed from the data alone, yet the disparity is strong enough to warrant focused investigation.
The finding also fits a broader concern in lung cancer care: diagnostic speed is shaped by more than tumor biology. It is shaped by how symptoms are interpreted, how quickly imaging is performed, whether abnormal results trigger immediate action, and how many handoffs occur before diagnosis is secured.
Why diagnostic interval length matters in lung cancer
Lung cancer is one of the clearest examples of a disease in which diagnostic delay can have cascading consequences. Symptoms such as cough, fatigue, chest pain and weight loss are often nonspecific, so imaging becomes the gatekeeper to diagnosis. Once imaging starts to recur across multiple modalities, the pathway can become more complex, and the chance of delay increases. Repeated scans may also reflect the need to differentiate malignancy from infection, inflammatory change or chronic structural lung disease, particularly when chest radiographs or earlier imaging do not provide a definitive answer.
This is where coordinated systems matter. Faster review of abnormal chest imaging, clearer escalation criteria, and tighter integration between primary care, radiology and respiratory services can reduce the number of patients who drift into prolonged workups or emergency care while awaiting diagnosis. The study aligns with the National Optimal Lung Cancer Pathway in signaling that timely follow-up after the first chest image should be a priority rather than an afterthought.
What the national data leave unresolved
Because this was a retrospective cohort study, it cannot determine whether prolonged intervals directly worsened outcomes, nor can it separate all clinical from organizational causes of delay. The dataset also cannot fully explain why some patients required multiple imaging modalities or why emergency attendance was so frequent. What it does show, with unusual clarity, is that prolonged diagnostic timelines are common and that they are accompanied by substantial acute-care use.
The most actionable signal is the concentration of delays after the first chest imaging step. If the first abnormal image does not prompt rapid next-stage evaluation, the pathway can fragment quickly. That is where diagnostic time accumulates, where patients re-present to emergency services, and where the chance of delivering earlier lung cancer treatment begins to slip.
For English lung cancer services, the message is direct: imaging capacity alone is not enough. The pathway needs faster follow-up, fewer handoffs, and better coordination between primary care and specialist assessment so that suspicious chest imaging turns into diagnosis without avoidable delay.